Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Ferracin

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Oncotarget|December 17, 2013
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patientsGian Matteo Rigolin, Elena Saccenti, Lara Rizzotto, et al.
Oncotarget|June 4, 2015
Absolute quantification of cell-free microRNAs in cancer patientsManuela Ferracin, Laura Lupini, Irene Salamon, et al.
Cancer Research|February 5, 2020
MiR-30e-3p Influences Tumor Phenotype through <i>MDM2</i>/<i>TP53</i> Axis and Predicts Sorafenib Resistance in Hepatocellular CarcinomaLaura Gramantieri, Daniela Pollutri, Martina Gagliardi, et al.
Non-Coding RNA|October 26, 2022
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung CancerStefano Miglietta, Giulia Girolimetti, Lorena Marchio, et al.
Frontiers in Immunology|January 30, 2023
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patientsGianluca Storci, Francesco Barbato, Francesca Ricci, et al.
Frontiers in Medicine|June 19, 2026
Cancer of unknown primary genomic profiling from cell-free DNA provides insights into CUP biology and vulnerabilitiesRoberta Roncarati, Beatrice Fontana, Ilaria Pace, et al.
Thrombosis and Haemostasis|November 7, 2014
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosisGiovanna Marchetti, Domenico Girelli, Carlotta Zerbinati, et al.
Cancer Research|August 19, 2007
Tumor suppressor functions of ARLTS1 in lung cancersSai Yendamuri, Francesco Trapasso, Manuela Ferracin, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 30, 2022
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancerMartina Mazzeschi, Michela Sgarzi, Donatella Romaniello, et al.
Translational Lung Cancer Research|December 15, 2022
ADK-VR2, a cell line derived from a treatment-naïve patient with <i>SDC4-ROS1</i> fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLCFrancesca Ruzzi, Stefania Angelicola, Lorena Landuzzi, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Oncotarget|December 17, 2013
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patientsGian Matteo Rigolin, Elena Saccenti, Lara Rizzotto, et al.
Oncotarget|June 4, 2015
Absolute quantification of cell-free microRNAs in cancer patientsManuela Ferracin, Laura Lupini, Irene Salamon, et al.
Cancer Research|February 5, 2020
MiR-30e-3p Influences Tumor Phenotype through <i>MDM2</i>/<i>TP53</i> Axis and Predicts Sorafenib Resistance in Hepatocellular CarcinomaLaura Gramantieri, Daniela Pollutri, Martina Gagliardi, et al.
Non-Coding RNA|October 26, 2022
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung CancerStefano Miglietta, Giulia Girolimetti, Lorena Marchio, et al.
Frontiers in Immunology|January 30, 2023
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patientsGianluca Storci, Francesco Barbato, Francesca Ricci, et al.
Frontiers in Medicine|June 19, 2026
Cancer of unknown primary genomic profiling from cell-free DNA provides insights into CUP biology and vulnerabilitiesRoberta Roncarati, Beatrice Fontana, Ilaria Pace, et al.
Thrombosis and Haemostasis|November 7, 2014
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosisGiovanna Marchetti, Domenico Girelli, Carlotta Zerbinati, et al.
Cancer Research|August 19, 2007
Tumor suppressor functions of ARLTS1 in lung cancersSai Yendamuri, Francesco Trapasso, Manuela Ferracin, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 30, 2022
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancerMartina Mazzeschi, Michela Sgarzi, Donatella Romaniello, et al.
Translational Lung Cancer Research|December 15, 2022
ADK-VR2, a cell line derived from a treatment-naïve patient with <i>SDC4-ROS1</i> fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLCFrancesca Ruzzi, Stefania Angelicola, Lorena Landuzzi, et al.
Pageof 19